(Q56051166)

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Contraception--the morning after

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Time for emergency contraception with levonorgestrel alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Emergency contraception: potential role of ulipristal acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Updated estimates of the effectiveness of the Yuzpe regimen of emergency contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Task Force on Postovulatory Methods of Fertility Regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

On the mechanisms of action of short-term levonorgestrel administration in emergency contraception.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Emergency contraception with mifepristone and levonorgestrel: mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Post-coital administration of levonorgestrel does not interfere with post-fertilization events in the new-world monkey Cebus apella

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Effectiveness of levonorgestrel emergency contraception given before or after ovulation--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Mifepristone: contraceptive and non-contraceptive uses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Progesterone receptor modulator for emergency contraception: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Levonorgestrel effects on serum androgens, sex hormone-binding globulin levels, hair shaft diameter, and sexual function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

A pilot study of the Copper T380A IUD and oral levonorgestrel for emergency contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Ectopic pregnancy and emergency contraceptive pills: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

The spectrum of endometrial pathology induced by progesterone receptor modulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591

The risk of venous thromboembolism in users of postcoital contraceptive pills

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.774591